Repeat Prostate-specific Antigen Testing
Repeat Prostate-Specific Antigen Testing is a longitudinal clinical measurement protocol involving the sequential administration of Prostate-Specific Antigen tests at specified intervals to monitor changes in serum biomarker levels for the purpose of prostate cancer screening, diagnosis, or disease progression assessment.
197
Publications
11.3K
Citations
981
Authors
386
Institutions
Publications per year
2017–2026
23
197
PCA3 Molecular Urine Assay for Prostate Cancer in Men Undergoing Repeat Biopsy
Leonard S. Marks, Yves Fradet, Ina L. Deras et al. · Urology · 2007 · 442 citations
Richard Choo, Laurence Klotz, Cyril Danjoux et al. · The Journal of Urology · 2002 · 359 citations
1–5 of 197
981
11
h-index
9
h-index
7
h-index
7
h-index
7
h-index
1–5 of 981
386
Erasmus MC
Rotterdam, The Netherlands
12 h-index
44 publications
3.6K citations
Memorial Sloan Kettering Cancer Center
New York, United States
10 h-index
33 publications
1.9K citations
University of Washington
Seattle, United States
8 h-index
20 publications
980 citations

Lund University
Lund, Sweden
8 h-index
17 publications
1.3K citations
University of Michigan
Ann Arbor, United States
8 h-index
47 publications
1.7K citations

University of Bristol
Bristol, United Kingdom
7 h-index
46 publications
3.2K citations
University of Oxford
Oxford, United Kingdom
7 h-index
21 publications
839 citations

Sunnybrook Health Science Centre
Toronto, Canada
7 h-index
29 publications
3.7K citations
1–8 of 386
43 publications · 3.4K citations
27
h-index
24 publications · 1.8K citations
21
h-index
15 publications · 1.4K citations
15
h-index
18 publications · 703 citations
15
h-index
7 publications · 424 citations
7
h-index
1–5